Yahoo! Finance Search - Finance Home - Yahoo! - Help

Sunday, December 11 2016 10:59am ET - U.S. Markets Closed.
Industry Center - Medical Laboratories & Research
Industry Center > Medical Laboratories & Research > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Health Care Plans
· Home Health Care
· Long-Term Care Facilities
· Medical Appliances & Equipment
· Medical Instruments & Supplies
· Medical Practitioners
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Medical Laboratories & Research News
Latest News
Saturday, Dec 10, 2016
·INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alere Inc. and Encourages Investors with Losses to Contact the Firm
- Sat 10:00 am ET
·ALERE INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates Alere Inc. - ALR
Business Wire - Fri 10:50 pm ET
Friday, Dec 9, 2016
·China Cord Blood Corporation Announces Results of 2016 Annual General Meeting
PR Newswire - Fri 8:49 am ET
·Genomic Health Announces Results from Multiple Oncotype DX Studies, Reinforcing its Impact in Delivering Precision Medicine to Breast Cancer Patients Around the World
PR Newswire - Fri 8:40 am ET
·INC Research Holdings Seen as Likely LabCorp Takeover Target
at - Fri 6:30 am ET
·SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Alere Inc. and Reminds Investors with Losses to Contact the Firm
- Thu Dec 8
·ALERE NOTICE: Rosen Law Firm Reminds Alere Inc. Investors of Important Deadline in Class Action Filed by Firm - ALR
Business Wire - Thu Dec 8
·Enzo Biochem reports 1Q loss
AP - Thu Dec 8
·Enzo Biochem Reports Improved First Quarter Results
Business Wire - Thu Dec 8
Thursday, Dec 8, 2016
·Agilent Technologies and Transcriptic Collaborate to Automate Discovery Biology
Business Wire - Thu Dec 8
·Clinical Utility of Biocept's Liquid Biopsy Platform Demonstrated in Study Results Presented at the 2016 San Antonio Breast Cancer Symposium
PR Newswire - Thu Dec 8
·Merger Costs, Missed Deal Have Analysts Questioning Quintiles
at - Thu Dec 8
·Invitae and TME Research Announce Landmark New Study to Evaluate Universal Genetic Testing of Breast Cancer Patients
Business Wire - Thu Dec 8
·THERMO FISHER SCIENTIFIC (IVGN) B.V. -- Moody's assigns P-2 rating to Thermo Fisher's new European CP Program
- Wed Dec 7
·Abbott sues Waltham's Alere to end $5.8 billion buyout
at - Wed Dec 7
Wednesday, Dec 7, 2016
·Abbott wants out of $5.8 billion Alere deal
at - Wed Dec 7
·[$$] Abbott Seeks to Terminate Alere Deal
at The Wall Street Journal Online - Wed Dec 7
·EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Alere Inc. and Encourages Investors with Losses to Contact the Firm
- Wed Dec 7
·Alere Issues Statement Regarding Abbott Lawsuit
PR Newswire - Wed Dec 7
·Abbott seeks to end buyout deal for Alere
AP - Wed Dec 7
More Latest News...

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Medical Laboratories & Research Headlines
More Finance RSS Feeds

Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?